Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
$ (29,888)
|
$ (39,822)
|
$ (69,697)
|
$ (135,657)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
30,982
|
36,317
|
63,184
|
72,131
|
| Accretion of contingent consideration |
|
|
0
|
419
|
| Provision for reduction in carrying value of certain assets |
|
|
|
1,088
|
| Loss on debt modification |
|
|
0
|
1,088
|
| (Gain) loss on disposition of assets |
113
|
2
|
465
|
62
|
| Deferred income tax expense (benefit) |
|
|
(934)
|
59,305
|
| Expenses not requiring cash |
|
|
4,948
|
(4,409)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
(6,853)
|
22,319
|
| Other assets |
|
|
(1,722)
|
(2,992)
|
| Accounts payable and accrued liabilities |
|
|
(8,235)
|
(6,862)
|
| Accrued income taxes |
|
|
1,276
|
(3,985)
|
| Net cash provided by operating activities |
|
|
(17,568)
|
(198)
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(26,559)
|
(16,257)
|
| Proceeds from the sale of assets |
|
|
185
|
1,387
|
| Net cash used in investing activities |
|
|
(26,374)
|
(14,870)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for remaining noncontrolling interest |
|
|
0
|
(3,375)
|
| Payments of contingent consideration |
|
|
0
|
(6,000)
|
| Proceeds from Issuance of Common Stock |
|
|
25,200
|
0
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
50,000
|
0
|
| Payments of Stock Issuance Costs |
|
|
(2,864)
|
0
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
(1,239)
|
0
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
(612)
|
(817)
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
(1,617)
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
70,485
|
(10,192)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
26,543
|
(25,260)
|
| Cash and cash equivalents, beginning of year |
|
|
119,691
|
134,294
|
| Cash and cash equivalents, end of period |
146,234
|
109,034
|
146,234
|
109,034
|
| Parent [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(29,888)
|
(39,824)
|
(69,696)
|
(135,657)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
1,088
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
(10,359)
|
49,167
|
| Expenses not requiring cash |
|
|
3,154
|
3,510
|
| Equity in net earnings of subsidiaries |
15,823
|
24,568
|
37,602
|
40,793
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Other assets |
|
|
(50,315)
|
(103,035)
|
| Accounts payable and accrued liabilities |
|
|
(37,753)
|
3,281
|
| Accrued income taxes |
|
|
71,942
|
21,711
|
| Net cash provided by operating activities |
|
|
(55,425)
|
(120,759)
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for remaining noncontrolling interest |
|
|
|
(3,375)
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
25,200
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
50,000
|
|
| Payments of Stock Issuance Costs |
|
|
2,864
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
(1,239)
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
612
|
(817)
|
| Excess tax benefit from stock-based compensation |
|
|
|
(1,617)
|
| Intercompany advances, net |
|
|
8,946
|
106,246
|
| Net cash used in financing activities |
|
|
79,431
|
102,054
|
| Net increase (decrease) in cash and cash equivalents |
|
|
24,006
|
(18,705)
|
| Cash and cash equivalents, beginning of year |
|
|
65,000
|
73,985
|
| Cash and cash equivalents, end of period |
89,006
|
55,280
|
89,006
|
55,280
|
| Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(8,698)
|
(16,502)
|
(24,287)
|
(30,816)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
20,270
|
23,314
|
41,458
|
46,439
|
| Accretion of contingent consideration |
|
|
|
419
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
26
|
(209)
|
242
|
(153)
|
| Deferred income tax expense (benefit) |
|
|
8,943
|
9,569
|
| Expenses not requiring cash |
|
|
120
|
(282)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
(13,787)
|
7,755
|
| Other assets |
|
|
32,013
|
102,496
|
| Accounts payable and accrued liabilities |
|
|
29,831
|
(5,737)
|
| Accrued income taxes |
|
|
(54,000)
|
(17,830)
|
| Net cash provided by operating activities |
|
|
20,533
|
111,860
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(18,726)
|
(7,499)
|
| Proceeds from the sale of assets |
|
|
25
|
121
|
| Net cash used in investing activities |
|
|
(18,701)
|
(7,378)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for remaining noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
(6,000)
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
361
|
(100,144)
|
| Net cash used in financing activities |
|
|
361
|
(106,144)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
2,193
|
(1,662)
|
| Cash and cash equivalents, beginning of year |
|
|
14,365
|
13,854
|
| Cash and cash equivalents, end of period |
16,558
|
12,192
|
16,558
|
12,192
|
| Non-Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(7,125)
|
(8,064)
|
(13,316)
|
(9,977)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
10,712
|
13,003
|
21,726
|
25,692
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
87
|
211
|
223
|
215
|
| Deferred income tax expense (benefit) |
|
|
482
|
569
|
| Expenses not requiring cash |
|
|
1,674
|
(7,637)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
6,934
|
14,564
|
| Other assets |
|
|
16,580
|
(2,453)
|
| Accounts payable and accrued liabilities |
|
|
(313)
|
(4,406)
|
| Accrued income taxes |
|
|
(16,666)
|
(7,866)
|
| Net cash provided by operating activities |
|
|
17,324
|
8,701
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(7,833)
|
(8,758)
|
| Proceeds from the sale of assets |
|
|
160
|
1,266
|
| Net cash used in investing activities |
|
|
(7,673)
|
(7,492)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for remaining noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
(9,307)
|
(6,102)
|
| Net cash used in financing activities |
|
|
(9,307)
|
(6,102)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
344
|
(4,893)
|
| Cash and cash equivalents, beginning of year |
|
|
40,326
|
46,455
|
| Cash and cash equivalents, end of period |
40,670
|
41,562
|
40,670
|
41,562
|
| Consolidation, Eliminations [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
15,823
|
24,568
|
37,602
|
40,793
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
0
|
0
|
| Expenses not requiring cash |
|
|
0
|
0
|
| Equity in net earnings of subsidiaries |
(15,823)
|
(24,568)
|
(37,602)
|
(40,793)
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Other assets |
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
0
|
0
|
| Accrued income taxes |
|
|
0
|
0
|
| Net cash provided by operating activities |
|
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for remaining noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
|
|
0
|
0
|
| Cash and cash equivalents, beginning of year |
|
|
0
|
0
|
| Cash and cash equivalents, end of period |
$ 0
|
$ 0
|
$ 0
|
$ 0
|